Introducing the first positive theranostic test for patients with metastatic colorectal cancer. The miRpredX 31-3p CE-IVD in vitro diagnostic kit is designed to quantify the expression of the microRNA miR-31-3p in FFPE samples from primary tumors obtained from patients with RAS WT metastatic colorectal cancer.
IntegraGen is exploring the clinical utility of measuring the expression of microRNAs in patients with advanced lung cancer in order to allow for a more personalize approach to cancer care.
IntegraGen is conducting groundbreaking research in the area of oncology biomarkers and the development of an advanced scientific software program that will aid in the interpretation of genome sequencing data obtained from cancer patients. Click here for the latest updates on our progress.